Gofen & Glossberg LLC Gilead Sciences, Inc. Transaction History

Gofen & Glossberg LLC

$3.89 Billion
Q4 2022

A detailed history of Gofen & Glossberg LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Gofen & Glossberg LLC holds 174,810 shares of GILD stock, worth $16.2 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

174,810

Previous 179,912 2.84%

Holding current value

$16.2 Million

Previous $11.1 Million 35.21%

% of portfolio

0.39%

Previous 0.31%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 13, 2023	SELL	$62.32 - $89.47 $317,956 - $456,475	-5,102 Reduced 2.84%	174,810 $15 Million
Q3 2022 Oct 13, 2022	SELL	$59.54 - $68.01 $56,146 - $64,133	-943 Reduced 0.52%	179,912 $11.1 Million
Q2 2022 Jul 14, 2022	SELL	$57.72 - $65.01 $1.33 Million - $1.49 Million	-22,983 Reduced 11.28%	180,855 $11.2 Million
Q1 2022 Apr 14, 2022	SELL	$57.92 - $72.58 $1.63 Million - $2.04 Million	-28,118 Reduced 12.12%	203,838 $12.1 Million
Q4 2021 Jan 25, 2022	SELL	$64.88 - $73.64 $344,123 - $390,586	-5,304 Reduced 2.24%	231,956 $16.8 Million
Q3 2021 Oct 13, 2021	SELL	$67.69 - $73.03 $567,445 - $612,210	-8,383 Reduced 3.41%	237,260 $16.6 Million
Q2 2021 Jul 13, 2021	SELL	$63.47 - $69.35 $1.31 Million - $1.43 Million	-20,684 Reduced 7.77%	245,643 $16.9 Million
Q1 2021 Apr 13, 2021	BUY	$60.0 - $68.46 $37,080 - $42,308	618 Added 0.23%	266,327 $17.2 Million
Q4 2020 Jan 15, 2021	SELL	$56.65 - $64.55 $168,363 - $191,842	-2,972 Reduced 1.11%	265,709 $15.5 Million
Q3 2020 Oct 09, 2020	SELL	$62.1 - $78.08 $74,209 - $93,305	-1,195 Reduced 0.44%	268,681 $17 Million
Q2 2020 Jul 13, 2020	SELL	$72.34 - $84.0 $165,224 - $191,856	-2,284 Reduced 0.84%	269,876 $20.8 Million
Q1 2020 Apr 14, 2020	SELL	$62.63 - $80.22 $80,604 - $103,243	-1,287 Reduced 0.47%	272,160 $20.3 Million
Q4 2019 Jan 28, 2020	SELL	$61.62 - $67.78 $416,551 - $458,192	-6,760 Reduced 2.41%	273,447 $17.8 Million
Q3 2019 Oct 10, 2019	SELL	$62.51 - $69.0 $94,640 - $104,466	-1,514 Reduced 0.54%	280,207 $17.8 Million
Q2 2019 Jul 12, 2019	BUY	$61.87 - $69.38 $2.8 Million - $3.14 Million	45,266 Added 19.14%	281,721 $19 Million
Q1 2019 Apr 11, 2019	BUY	$62.53 - $70.05 $2.45 Million - $2.74 Million	39,139 Added 19.84%	236,455 $15.4 Million
Q4 2018 Jan 15, 2019	SELL	$60.54 - $79.0 $590,507 - $770,566	-9,754 Reduced 4.71%	197,316 $12.3 Million
Q3 2018 Oct 11, 2018	SELL	$71.28 - $78.92 $241,496 - $267,380	-3,388 Reduced 1.61%	207,070 $16 Million
Q2 2018 Jul 11, 2018	SELL	$64.88 - $75.68 $252,837 - $294,924	-3,897 Reduced 1.82%	210,458 $14.9 Million
Q1 2018 Apr 11, 2018	SELL	$72.84 - $88.8 $469,380 - $572,227	-6,444 Reduced 2.92%	214,355 $16.2 Million
Q4 2017 Jan 11, 2018	SELL	$71.15 - $83.52 $1.58 Million - $1.86 Million	-22,249 Reduced 9.15%	220,799 $15.8 Million
Q3 2017 Nov 16, 2017	SELL	$72.11 - $85.47 $1.14 Million - $1.35 Million	-15,748 Reduced 6.09%	243,048 $19.7 Million
Q2 2017 Aug 16, 2017	BUY	N/A	258,796	258,796 $18.3 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gofen & Glossberg LLC , based on Form 13F filings with the SEC.

News

Stay updated on Gofen & Glossberg LLC with notifications on news.

Account

Gofen & Glossberg LLC Gilead Sciences, Inc. Transaction History